Data / Form D filings / CardioGenics Inc.
CardioGenics Inc.: Form D filing
CardioGenics Inc., a biotechnology company in Mississauga, filed a Form D with the SEC in 2009. The latest, on August 17, 2009, reports $2.7 million sold of a $2.7 million offering to 16 investors.
Find out what CardioGenics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6295 NORTHAM DRIVE, UNIT 8, Mississauga, L4V 1
- Phone
- (905) 673-8501
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1470449
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 17, 2009 | New notice | $2,715,000 | $2,715,000 | $0 | 16 | Jul 31, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Carville | Executive Officer | |
| Yahia Gawad | Executive Officer, Director | |
| Alexander Reid | Director | |
| Chandra Panchal | Director | |
| James Essex | Executive Officer | |
| J. Neil Tabatznik | Director | |
| Linda J. Sterling | Executive Officer, Director |
Every Form D from the week of Aug 17, 2009 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CardioGenics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.